The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the dutch bioday registry

HIGHLIGHTS

• who: Voorberg and colleagues from the Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands have published the research work: The longu2010term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitisu201452 week results from the Dutch BioDay Registry, in the Journal: (JOURNAL)
• what: The authors evaluated the long-term 52 weeks on the HECSI of 50% (HECSI-50), 75% (HECSI-75), and_(52 weeks) effect of dupilumab on HE in patients with AD. The results of this study show that dupilumab might be an effec- administration . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.